BRBrian D. Ross

Brian D. Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brian D. Ross has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy

    by Alexander P Lin, Saadallah Ramadan, Robert A Stern, Hayden C Box, Christopher J Nowinski, Brian D Ross, Carolyn E Mountford

    Introduction: The goal was to identify which neurochemicals differ in professional athletes with repetitive brain trauma (RBT) when compared to healthy controls using a relatively new technology, in vivo Localized COrrelated SpectroscopY (L-COSY). Methods: To achieve this, L-COSY was used to examine five former professional male athletes with 11 to 28 years of exposure to contact sports. Each athlete who had had multiple symptomatic concussions and repetitive sub concussive trauma during their career was assessed by an experienced neuropsychologist. All athletes had clinical symptoms including headaches, memory loss, confusion, impaired judgment, impulse control problems, aggression, and depression. Five healthy men, age and weight matched to the athlete cohort and with no history of brain trauma, were recruited as controls. Data were collected from the posterior cingulate gyrus using a 3 T clinical magnetic resonance scanner equipped with a 32 channel head coil. Results: The variation of the method was calculated by repeated examination of a healthy control and phantom and found to be 10% and 5%, respectively, or less. The L-COSY measured large and statistically significant differences (P ≤0.05), between healthy controls and those athletes with RBT. Men with RBT showed higher levels of glutamine/glutamate (31%), choline (65%), fucosylated molecules (60%) and phenylalanine (46%). The results were evaluated and the sample size of five found to achieve a significance level P = 0.05 and a power of 90%. Differences in N-acetyl aspartate and myo-inositol between RBT and controls were small and were not statistically significance. Conclusions: A study of a small cohort of professional athletes, with a history of RBT and symptoms of chronic traumatic encephalopathy when compared with healthy controls using 2D L-COSY, showed elevations in brain glutamate/glutamine and choline as recorded previously for early traumatic brain injury. For the first time increases in phenylalanine and fucose are recorded in the brains of athletes with RBT. Larger studies utilizing the L-COSY method may offer an in-life method of diagnosis and personalized approach for monitoring the acute effects of mild traumatic brain injury and the chronic effects of RBT.


  • PASADENA hyperpolarization of 13C biomolecules: equipment design and installation

    by Jan-Bernd Hövener, Eduard Y. Chekmenev, Kent C. Harris, William H. Perman, Larry W. Robertson, Brian D. Ross, Pratip Bhattacharya

    Object The PASADENA method has achieved hyperpolarization of 16–20% (exceeding 40,000-fold signal enhancement at 4.7 T), in liquid samples of biological molecules relevant to in vivo MRI and MRS. However, there exists no commercial apparatus to perform this experiment conveniently and reproducibly on the routine basis necessary for translation of PASADENA to questions of biomedical importance. The present paper describes equipment designed for rapid production of six to eight liquid samples per hour with high reproducibility of hyperpolarization. Materials and methods Drawing on an earlier, but unpublished, prototype, we provide diagrams of a delivery circuit, a laminar-flow reaction chamber within a low field NMR contained in a compact, movable housing. Assembly instructions are provided from which a computer driven, semi-automated PASADENA polarizer can be constructed. Results Together with an available parahydrogen generator, the polarizer, which can be operated by a single investigator, completes one cycle of hyperpolarization each 52 s. Evidence of efficacy is presented. In contrast to competing, commercially available devices for dynamic nuclear polarization which characteristically require 90 min per cycle, PASADENA provides a low-cost alternative for high throughput. Conclusions This equipment is suited to investigators who have an established small animal NMR and wish to explore the potential of heteronuclear (13 C and 15 N) MRI, MRS, which harnesses the enormous sensitivity gain offered by hyperpolarization.


  • Quality assurance of PASADENA hyperpolarization for 13C biomolecules

    by Jan-Bernd Hövener, Eduard Y. Chekmenev, Kent C. Harris, William H. Perman, Thao T. Tran, Brian D. Ross, Pratip Bhattacharya

    Object Define MR quality assurance procedures for maximal PASADENA hyperpolarization of a biological 13C molecular imaging reagent. Materials and methods An automated PASADENA polarizer and a parahydrogen generator were installed. 13C enriched hydroxyethyl acrylate, 1-13C, 2,3,3-d3 (HEA), was converted to hyperpolarized hydroxyethyl propionate, 1-13C, 2,3,3-d3 (HEP) and fumaric acid, 1-13C, 2,3-d2 (FUM) to hyperpolarized succinic acid, 1-13C, 2,3-d2 (SUC), by reaction with parahydrogen and norbornadiene rhodium catalyst. Incremental optimization of successive steps in PASADENA was implemented. MR spectra and in vivo images of hyperpolarized 13C imaging agents were acquired at 1.5 and 4.7 T. Results Application of quality assurance (QA) criteria resulted in incremental optimization of the individual steps in PASADENA implementation. Optimal hyperpolarization of HEP of P = 20% was achieved by calibration of the NMR unit of the polarizer (B 0 field strength ± 0.002 mT). Mean hyperpolarization of SUC, P = [15.3 ± 1.9]% (N = 16) in D 2O, and P = [12.8 ± 3.1]% (N = 12) in H 2O, was achieved every 5–8 min (range 13–20%). An in vivo 13C succinate image of a rat was produced. Conclusion PASADENA spin hyperpolarization of SUC to 15.3% in average was demonstrated (37,400 fold signal enhancement at 4.7 T). The biological fate of 13C succinate, a normally occurring cellular intermediate, might be monitored with enhanced sensitivity.


  • Towards hyperpolarized 13C-succinate imaging of brain cancer

    by Pratip Bhattacharya, Eduard Y. Chekmenev, William H. Perman, Kent C. Harris, Alexander P. Lin, Valerie A. Norton, Chou T. Tan, Brian D. Ross, Daniel P. Weitekamp


  • Open Access

    Impact of evidence‐based medicine on magnetic resonance spectroscopy

    by Alexander P. Lin, Thao T. Tran, Brian D. Ross

    Magnetic resonance spectroscopy (MRS) is a robust, non‐invasive means of defining aspects of human neurochemistry. After more than two decades, it is clear that in addition to its scientific interest, MRS has diagnostic value in tumor diagnosis, prognosis, therapeutic outcome, dementia diagnosis and prognosis, multiple sclerosis, infections, trauma, development, stroke, perinatal ischemia, xenobiotics and inborn errors (as determined from a meta‐analysis included in this paper). However, in many healthcare systems, a new radiological technique requires evidence‐based medicine (EBM) before it is recommended for reimbursement. Much of the reason why MRS is thought to be non‐reimbursable in the USA is due to recent announcements that this 15‐year‐old technique is still considered ‘investigational’ by these EBM assessments. An analysis is presented of the technology assessments that brought about this situation. Based on the conclusions of the EBM assessments, strategies are suggested that involve all entities responsible for spectroscopy including the scientists' role in ensuring the future for clinical spectroscopy. Copyright © 2006 John Wiley & Sons, Ltd.


  • Magnetic Resonance Criteria for Future Trials of Cardiac Resynchronization Therapy

    by Benjamin England, Andrew Lee, Thao Tran, Heather Faw, Phillip Yang, Alexander Lin, Patrick Colletti, Fernando Roth, Brian D. Ross

    Current patient selection criteria for Cardiac Resynchronization Therapy (CRT), an efficacious treatment for heart failure, include no measure of disconjugate cardiac contractility other than prolonged QRS on electrocardiogram. Using cardiac magnetic resonance imaging, we examined the roles of cardiac asymmetry, asynchrony, and circumferential strain in DCC with the principal aim of generating a robust numerical index for use in future trials of CRT. Standard cardiac magnetic resonance imaging was done on a GE 1.5 Tesla Signa LX MRI clinical scanner (GE Healthcare, Milwaukee, WI, USA) and analyzed by MASS Analysis (MEDIS, Leiden, The Netherlands). The methods were evaluated in eleven patients with advanced heart failure due to ischemic and non-ischemic cardiomyopathy, who did not qualify under current criteria for CRT, five CRT candidates pre-op and eleven normal subjects. Using t-test and standardized differences (SD = sd/diff, Power (N) = number of patients to reach p < .05) we determined efficacy. Indices of asymmetry and asynchrony (Ism and Isn, respectively) could be measured with accuracy and provided excellent statistical power when used as surrogate markers to delineate heart failure and CRT patients from control subjects. Asymmetry and asynchrony in heart contraction are both critical components of dilated cardiomyopathy that can be improved by CRT. Magnetic resonance asynchrony is efficacious in screening patients and should now be compared with recently published echocardiography data to improve outcome for this costly but valuable therapy.


  • Ultra-fast three dimensional imaging of hyperpolarized 13C in vivo

    by P. Bhattacharya, K. Harris, A. P. Lin, M. Mansson, V. A. Norton, W. H. Perman, D. P. Weitekamp, B. D. Ross

    Objective: PASADENA, a chemical method of enhancing nuclear spin polarization has demonstrated 13C polarizations of order unity for the nascent products of molecular addition by parahydrogen. The extreme brevity of signal enhancement obtained by hyperpolarization requires improved 13C MR in vivo imaging techniques for their optimum utility. Materials and Methods: 13C imaging sequences, including 13C 3D FIESTA, were compiled for a GE LX 1.5 T clinical MR scanner. Two water soluble 13C imaging agents were hyperpolarized utilizing parahydrogen and an automated polarizer. 13C polarization was quantified in flow phantoms and in rats with jugular vein catheters. Results: Fast 3D FIESTA 13C MR imaging technique acquired sequential 3D images (3.66 s/acquisition) with superior SNR. Hyperpolarized 13C solutions and vascular phantoms achieved a maximum signal of 26,624±593. In vivo 13C MR images of the cardiopulmonary circulation showed maximum 13C signal of 2,402±158. 13C images acquired within 3.66 s showed signal enhancement over 10,000 compared to equilibrium polarization. Conclusion: 3D-FIESTA was effective for sub-second in vivo imaging of hyperpolarized 13C reagents produced in a custom-built parahydrogen polarizer. Application to 13C hyperpolarized by parahydrogen is demonstrated in vitro and in vivo


  • Gd-Enhanced Cardiovascular MR Imaging to Identify Left Ventricular Pseudoaneurysm

    by Thao Tran, Brian Ross, Patrick Colletti, Russell Ching

    A pseudoaneurysm occurs when incomplete rupture of the heart seals within organizing thrombus, hematoma, and pericardium and maintains communication with the left ventricle. A pseudoaneurysm may cause arterial emboli and drain off a considerable portion of ventricular stroke volume. Cardiovascular magnetic resonance imaging proves to be an adequate technique to not only identify pseudoaneurysms but also quantify function measurements of the left ventricle and allow for projections of post-surgical function. When complemented with myocardial delayed enhancement, it is the best technique for identifying the viability of myocardial tissue, an important aspect in surgical planning.


  • Open Access

    Clinical experience with 13C MRS in vivo

    by Brian Ross, Alexander Lin, Kent Harris, Pratip Bhattacharya, Brian Schweinsburg

    13C MRS was installed on a clinical scanner at 1.5 T in order to facilitate integrated MR examinations of human brain disorders. Using a simplified protocol, (1‐13C) glucose and/or (1‐13C) acetate were administered orally or by intravenous infusion. 13C spectra of diagnostic quality were acquired in more than 100 consecutive studies. Novel 13C neurochemical data contributed to the understanding of Alzheimer's, Canavan's, mitochondrial and hepatic encephalopathy, epilepsy and normal brain development. 13C MRS uncovered hitherto unknown disorders of NAA‐synthesis, glutamate neurotransmission, TCA‐cycle and glycolysis. Despite low inherent signal‐to‐noise, natural abundance 13C MRS showed diagnostic promise. 13C MRS is feasible in a clinical setting, at reasonable cost in neonates, children, adults and elderly patients. Copyright © 2003 John Wiley & Sons, Ltd.